|
|||||||||||||||||||||||||||||||
| Poster No. |
Presenter | Title | |
| P-01 | Yutaka Takebe [NIID, Japan / NCAIDS/STD China] |
Reconstructing the epidemic history of HIV-1 subtype B' that is responsible for explosive blood-borne epidemics in Asia: its public health implications and the relevance for future vaccine strategies | |
| P-02 | Atsushi Koito [Kumamoto Univ.] |
Retrovirus, retroelement restrictions by APOBEC enzymes | |
| P-03 | Tetsuo Narumi [Tokyo Medical and Dental Univ.] |
SAR study of small molecular CD4 mimics targeting the dynamic supramolecular mechanism of HIV entry and their hybrid molecules with a CXCR4 antagonist | |
| P-04 | Manabu Aoki [Kumamoto Health Science Univ.] |
Identification of amino acid substitutions associated with compromized tipranavir’s dimerization inhibition and enzymatic inhibition | |
| P-05 | Kazuhiko Maeda [Kumamoto Univ.] |
GANP promotes APOBEC3G encapsidation in virions to reduce viral infectivity | |
| P-06 | Koichi Hamada [Kumamoto Univ.] |
Critical Role of the PI3K/PTEN/GSK-3 Signaling Pathway in HIV latent infected cells | |
| P-07 | Takeo Kuwata [Kumamoto Univ.] |
Biased induction of neutralizing antibodies with particular specificity and gene usage in SIVsmH635FC-infected macaques | |
| P-08 | Kazuaki Monde [Kumamoto Univ.] |
Coassembly of HERV-K Gag with HIV-1 Gag | |
| P-09 | Nobuyo Higashi-Kuwata [Kumamoto Univ.] |
Alteration of the dynamics of HIVmc dissemination in huPBMC NOJ mice under Raltegravir administration | |
| P-10 | Tsunefusa Hayashida [NCGM/Kumamoto Univ.] |
Trends in early and late diagnosis of HIV infection analyzed by BED assay | |
| P-11 | Koji Watanabe [NCGM/Kumamoto Univ.] |
Clinical and epidemiological features of amebiasis in HIV-1-infected Japanese men | |
| P-12 | Takeshi Nishijima [NCGM/Kumamoto Univ.] |
Renal function declines more with tenofovir use than abacavir among low-body weight treatment-naïve patients with HIV infection | |
| P-13 | Atsuko Hachiya [NCGM] |
HIV-1 Reverse Transcriptase (RT) Polymorphism 172K, Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors | |
| P-14 | Shigeyoshi Harada [Kumamoto Univ.] |
Impact of raltegravir pressure on the selection of HIV-1 envelope sequences in vitro | |
| P-15 | Hiromi Terasawa [Kumamoto Univ.] |
A single amino acid mutation in V3 loop of a CRF01_AE HIV-1 responsible for reversion of dual-X4 to dual-R5 HIV-1 by a CXCR4 antagonist in vitro | |
| P-16 | Yusuke Nakano [Kumamoto Univ.] |
The impact of enhanced CCR5 homo-oligomerization by CCR5 inhibitors on HIV-1 infection | |
| P-17 | Tomofumi Nakamura [Kumamoto Univ.] |
Visualization and quantification of the multimer formation of HIV-1 integrase using biomolecular fluorescent complementation (BiFC) | |
| P-18 | Masayuki Amano [Kumamoto Univ.] |
A Novel Oxatricyclic-ligand-Containing Nonpeptidic Protease Inhibitor (PI) GRL-0519A Potent against Multi-PI-Resistant HIV In Vitro | |
| P-19 | Hiroshi Arai [Tokyo Medical and Dental Univ.] |
Design, synthesis and biological evaluation of CD4 mimics targeting the interaction with Asp368 and Val430 in gp120 | |
| P-20 | Kazuo Suzuki [St Vincent's Centre for Applied Medical Research, Australia] |
Sequence specific induction of HIV-1 transcriptional gene silencing targeting NF-kB sequences by siRNA without any off-target effects of other NF-B driven genes | |
| P-21 | Eriko Kudo [Kumamoto Univ.] |
Inhibition of HIV-1 replication by photo-degrading a fullerene-sugar hybrids | |
| P-22 | Ryusho Kariya [Kumamoto Univ.] |
HIV protease inhibitor inhibits the growth of primary effusion lymphoma and induces apoptosis | |
| P-23 | Kouki Matsuda [Kumamoto Univ.] |
Cepharanthine controls HIV-1 infection by inhibiting the fusion of virus | |
| P-24 | Masako Shimamoto [Kumamoto Univ.] |
Inhibition of Cell Cycle Progression by Proton Pump Inhibitor in Primary Effusion Lymphoma | |
| P-25 | Peter Gee [Kyoto Univ.] |
Biochemical characterization of the HIV-1 restriction factor SAMHD1 | |
| P-26 | Ken Kono [Osaka Univ.] |
Functional and geographical diversity of antiretroviral host factor TRIMCyp in Cynomolgus macaque (Macaca fascicularis) | |
| P-27 | Nopporn Chutiwitoonchai [Kumamoto Univ.] |
Interferon-inducible IFITM family proteins reduce HIV-1 production | |
| P-28 | Hasan Md. Zafrul [Kumamoto Univ.] |
Subtle effect of HLA class I-driven selective forces on the variability of HIV-1 accessory genes | |
| P-29 | Philip Mwimanzi [Kumamoto Univ.] |
Population analysis of viral replication capacity by nef alleles of HIV elite controllers | |
| P-30 | Michihiro Hashimoto [Kumamoto Univ.] |
Activation of brain microglial cells by extracellular HIV-1 Nef proteins | |
| P-31 | Masateru Hiyoshi [Kumamoto Univ.] |
HIV-1 Nef Perturbs the Function, Structure, and Signaling of the Golgi through the Src Kinase Hck | |
| P-32 | Takashi Chihara [Kumamoto Univ.] |
Preferential activation of anti-inflammatory M2-type macrophages by HIV-1 proteins | |
| P-33 | Katsuhiro Io [Kyoto Univ.] |
Phosphorylation of p53 is enhanced by HIV-1 Vif and required for Vif-induced G2 cell cycle arrest and apoptosis | |
| P-34 | Pattaravadee Srikoon [Kumamoto Univ.] |
Dual NK activities in minor subpopulation, CD56dimCD16- NK cells in cord blood and periphery and its association with NK defects in HIV-1-infection | |
| P-35 | Manthana Mitchai [Khon Kean Hospital, Thailand] |
Function and characterization of CD56-/CD16+ natural killer cell in viremic and treated aviremic HIV infected patient | |
| P-36 | Shinichiro Hattori [Kumamoto Univ.] |
Expansion of Human CD3-CD56+ NK Cells and HIV-1 Infection in NOD/SCID/Jak3-/- Mouse | |
| P-37 | Chihiro Motozono [Cardiff Univ., UK] |
The cross-reactivity footprints of HIV-specific CTLs | |
| P-38 | Nozomi Kuse [Kumamoto Univ.] |
Selection of Pol283-8V mutant by Pol283-8-specific CTLs in long-term non progressors of HLA-B*51:01+Japanese hemophiliacs | |
| P-39 | Hayato Murakoshi [Kumamoto Univ.] |
Comprehensive analysis of HIV-1-specific CD8+ T cell responses in chronically HIV-1 clade B-infected Japanese cohort | |
| P-40 | Tomohiro Akahoshi [Kumamoto Univ.] |
Role of cross-reactive CTLs in selection of HIV-1escape mutant | |
| P-41 | Takayuki Chikata [Kumamoto Univ.] |
HLA-Associated Viral Polymorphism in Chronically HIV-1-Infected Japanese Cohort | |
| P-42 | Yasuhiro Maruta [Kumamoto Univ.] |
Construction of neutralizing antibody fragments for efficient access to V3 epitope | |
| P-43 | Kristel Ramírez [Kumamoto Univ.] |
Novel CD4-induced monoclonal antibodies (MAbs) with cross-neutralizing activity against primary isolates of HIV-1 B and C subtypes | |
| P-44 | Teppei Toda [Kumamoto Univ.] |
Dynamic changes in antigenic membrane fusion epitopes initiated by interactions between HIV-1 envelope proteins and CD4/CXCR4 | |
| P-45 | Kyoko Kurihara [NIID/Univ. of Tokyo] |
Combination of intranasal and intramuscular Sendai virus vector immunization | |
| P-46 | Yusuke Takahara [NIID/Univ. of Tokyo] |
Impact of therapeutic vaccination during HAART on CTL immunodominance in SIV infection | |
| P-47 | Masayuki Ishige [NIID/Kumamoto Univ.] |
Analysis of dominantly replicated virus in the acute phase by X4-type and/or R5-type HIV-1 infection in humanized NOD/SCID/Jak3-null mice | |
| P-48 | Hiromi Ogata-Aoki [Kumamoto Univ.] |
Early Phase Dynamics of HIV Infection in hPBMC-Transplanted NOD/SCID/Jak3-/- Mice Using Infectious HIV Carrying a Fluorescent Protein, mCherry | |
| P-49 | Yoshinori Sato [Kumamoto Univ.] |
Elicitation of human effector CD8+ T cells in HIV-1-infected HLA-B*51:01 transgenic humanized mice | |
